biotech

Pycnogenol® 190 Times More Potently than Prescription Diabetes Medications

Filed in archive Drugs, Vaccines and Therapeutics , Food and Agriculture on February 13, 2007

. Previously, pycnogenol has been demonstrated to reduce diabetic leg ulcers as well as reduce symptoms of attention deficit hyeractivity disorder (ADHD).

A study to be published in Diabetes Research and Clinical Practice also reveals that Pycnogenol delays the uptake of glucose from a meal 190 times more than synthetic prescription alpha-glucosidase inhibitors such as Precose®, and is thus more potent in preventing the typical high glucose peak in the blood stream after a meal.
"The high concentration of procyanidins (flavonoids) found in Pycnogenol® is responsible for demonstrating these excellent results," said Högger. According to Högger, the large procyanidin molecules were found to be particularly active for inhibiting the activity of alpha-glucosidase, thus demonstrating such notable results. "The carbohydrates enter the blood stream steadily over prolonged periods of time, which makes meals last longer and prolong satiety."

Pycnogenol® is a natural plant extract originating from the bark of the maritime pine that grows along the coast of southwest France.


Permalink: Pycnogenol® 190 Times More Potently than Prescription Diabetes Medications

Tags: pycnogenol  diabetes  alternative+medicine  dietary+supplement  biotech  times+more  prescription+diabetes 

Vote for Pycnogenol® 190 Times More Potently than Prescription Diabetes Medications:

  • Currently 6.75/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.75 out of 4 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells